Literature DB >> 15854749

The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal rats.

Estuardo Figueroa1, Laura E Gordon, Pamela W Feldhoff, Herbert A Lassiter.   

Abstract

The role of complement in post-ischemic cerebral injury is incompletely understood. Therefore, experiments were designed to test the effect of complement depletion on cerebral infarct volume in adult rats and cerebral atrophy in neonatal rats. Cerebral infarcts were induced in adult rats by transient filamentous occlusion of the right middle cerebral artery (MCAO). Cerebral atrophy was induced by subjecting 7-day-old rats to ligation of the right common carotid artery followed by 2.5h of hypoxia (8% O2). Forty-eight hours after MCAO, coronal sections of adult brains were obtained and stained with 2,3,5-triphenyl tetrazolium chloride. The infant rat brains were removed for analysis 6 weeks after the hypoxic-ischemic insult. Volumes of infarcts and normal hemispheric parenchyma were quantified by computer-based planimetry. Twenty-four hours prior to MCAO (adults) or hypoxia-ischemia (neonates), each animal received an i.p. injection of either 1 mcg/g body weight cobra venom factor (CVF; adult n=11; neonatal n=20) or normal saline (adult n=12; neonatal n=24). In the neonates, a second dose of CVF or saline was administered 2 days after hypoxia-ischemia. The administration of CVF significantly reduced: (1) post-ischemic cerebral infarct volume in the adults and (2) post-hypoxic-ischemic cerebral atrophy in the neonates. Therefore, complement activation augmented post-ischemic cerebral injury in adult and neonatal rats. Complement depletion induced by CVF significantly reduced post-ischemic cerebral infarct volume and atrophy in adult and neonatal rats.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15854749     DOI: 10.1016/j.neulet.2005.01.027

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

1.  Protective effects of hypothalamic proline-rich peptide and cobra venom Naja Naja Oxiana on dynamics of vestibular compensation following unilateral labyrinthectomy.

Authors:  Armen A Galoyan; Naser Khalaji; Lilja E Hambardzumyan; Larisa P Manukyan; Irina B Meliksetyan; Vergine A Chavushyan; Vaghinak H Sarkisian; John S Sarkissian
Journal:  Neurochem Res       Date:  2010-08-12       Impact factor: 3.996

Review 2.  Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors:  T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

Review 3.  Complement inhibition as a proposed neuroprotective strategy following cardiac arrest.

Authors:  Brad E Zacharia; Zachary L Hickman; Bartosz T Grobelny; Peter A DeRosa; Andrew F Ducruet; E Sander Connolly
Journal:  Mediators Inflamm       Date:  2010-01-26       Impact factor: 4.711

4.  The contribution of mannose binding lectin to reperfusion injury after ischemic stroke.

Authors:  Helena Morrison; Jennifer Frye; Grace Davis-Gorman; Janet Funk; Paul McDonagh; Gregory Stahl; Leslie Ritter
Journal:  Curr Neurovasc Res       Date:  2011-02       Impact factor: 1.990

5.  Complement component c1q mediates mitochondria-driven oxidative stress in neonatal hypoxic-ischemic brain injury.

Authors:  Vadim S Ten; Jun Yao; Veniamin Ratner; Sergey Sosunov; Deborah A Fraser; Marina Botto; Baalasubramanian Sivasankar; B Paul Morgan; Samuel Silverstein; Raymond Stark; Richard Polin; Susan J Vannucci; David Pinsky; Anatoly A Starkov
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

6.  Relation of platelet C4d with all-cause mortality and ischemic stroke in patients with systemic lupus erythematosus.

Authors:  Amy H Kao; Christine A McBurney; Abdus Sattar; Apinya Lertratanakul; Nicole L Wilson; Sarah Rutman; Barbara Paul; Jeannine S Navratil; Andrea Scioscia; Joseph M Ahearn; Susan Manzi
Journal:  Transl Stroke Res       Date:  2013-10-27       Impact factor: 6.829

7.  Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death.

Authors:  Thiruma V Arumugam; Sung-Chun Tang; Justin D Lathia; Aiwu Cheng; Mohamed R Mughal; Srinivasulu Chigurupati; Tim Magnus; Sic L Chan; Dong-Gyu Jo; Xin Ouyang; David P Fairlie; Daniel N Granger; Alexander Vortmeyer; Milan Basta; Mark P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

8.  Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice.

Authors:  Denise Harhausen; Uldus Khojasteh; Philip F Stahel; B Paul Morgan; Wilfried Nietfeld; Ulrich Dirnagl; George Trendelenburg
Journal:  J Neuroinflammation       Date:  2010-03-04       Impact factor: 8.322

Review 9.  Does inflammation after stroke affect the developing brain differently than adult brain?

Authors:  Zinaida S Vexler; Midori A Yenari
Journal:  Dev Neurosci       Date:  2009-08-11       Impact factor: 2.984

10.  Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage.

Authors:  Matthew C Garrett; Marc L Otten; Robert M Starke; Ricardo J Komotar; Paola Magotti; John D Lambris; Michal A Rynkowski; E Sander Connolly
Journal:  Brain Res       Date:  2009-05-04       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.